A detailed history of Pacific Center For Financial Services transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Pacific Center For Financial Services holds 81 shares of CRSP stock, worth $3,828. This represents 0.0% of its overall portfolio holdings.

Number of Shares
81
Previous 81 -0.0%
Holding current value
$3,828
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$70.09 - $111.29 $5,677 - $9,014
81 New
81 $6,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.69B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Pacific Center For Financial Services Portfolio

Follow Pacific Center For Financial Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacific Center For Financial Services, based on Form 13F filings with the SEC.

News

Stay updated on Pacific Center For Financial Services with notifications on news.